Global Licensing Avaan leverages licensing and development partnerships across global resources, with a focus on emerging markets like India and China. This presents sales opportunities to supply development services, regulatory strategy support, and regional commercialization partnerships.

Specialized Focus Primary drug candidate focus areas are CNS, Oncology and Diabetes. Targeted BD conversations can center on translational research, preclinical-to-clinic development acceleration, and access to cross-border clinical execution expertise.

Executive Experience Founding team and strategic advisory board include former Pfizer and Schering-Plough leaders with deep registration and global development track records, enabling selling points around risk reduction, regulatory navigate capability, and strategic co-development.

Strategic Alliances Existing high-level industry connections signal opportunities for joint ventures, licensing deals, and advisory-driven partnerships that leverage established networks to accelerate candidate portfolio expansion.

Financial Position Current revenue range is modest, suggesting a need for upfront licensing deals, milestone-based funding, and CRO/CDMO partnerships to monetize early-stage assets while scaling development and commercialization activities.